XJAM: ELITE
- Last Close 2.21
- Sector Healthcare
- Industry Diagnostics & Research
- Investment Style
- Day Range — – —
- Year Range — – —
- Market Cap —
- Volume / Avg — / —
- Price / Sales —
- Price / Book —
- Forward Div Yield 0.90%
- Trailing Div Yield —
Morningstar‘s Stock Analysis ELITE
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile ELITE
Elite Diagnostic Ltd provides diagnostic and research services. The company offers various services such as Interventional Radiology Procedures, Magnetic Resonance Imaging (MRI), Computed Tomography (CT Scan), Ultrasound, X-Ray, Fluoroscopy, Endoscopic Ultrasound, the only one of its kind in the Caribbean. The company's revenue is derived mainly from diagnostic imaging services.
Competitors & Peers
Morningstar does not cover competitors or peers for this firm.
FAQs for Elite Diagnostic Ltd Stock
Yes. ELITE has a forward dividend yield of 0.91%.
See
ELITE’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
ELITE’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare ELITE’s historical performance against its industry peers and the overall market.